Abeona Therapeutics share price logo

Abeona Therapeutics

NASDAQ: ABEO

Small Cap

$6.00

-0.01

(-0.25%)

Live

as on

Abeona Therapeutics Stock Performance

as on August 28, 2026 at 2:35 am IST

  • Day's Low

    Day's High

    $5.93
    $6.04
    downward going graph

    1.17%

    Downside

    0.67%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $4.00
    $7.65
    downward going graph

    33.33%

    Downside

    27.50%

    Upside

    downward going graph

Abeona Therapeutics share price movements today

Previous Close
$6.01
Open
$6.01
Volume
122.7K
Market Cap
$346.5M
Day's Low - High
$5.93 - $6.04
52 Week Low - High
$4.00 - $7.65

Abeona Therapeutics Historical Returns

1 Month Return
+ 1.31 %
3 Month Return
+ 9.14 %
1 Year Return
-10 %
3 Year Return
+ 58.02 %
5 Year Return
-81.04 %

Abeona Therapeutics Stock Fundamentals & Key Indicators

Check Abeona Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$346.5M

EPS (TTM)

-0.8733

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-80.8M

Revenue (TTM)

25.5M

Profit Margin

-246.42%

Return On Equity TTM

-43.13%

Abeona Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Abeona Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$346.5M-81.04%NA-246.42%NA
BUY$45.3B641.42%NA0.00%NA
BUY$138.8B176.54%31.9535.00%NA
BUY$55.4B-58.45%NA-141.43%NA
BUY$85.3B25.67%20.6227.87%44.39%

Stock Returns calculator for Abeona Therapeutics Stock including INR - Dollar returns

The Abeona Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Abeona Therapeutics investment value today

Current value as on today

₹94,762

Returns

-₹5,238

(-5.24%)

Returns from Abeona Therapeutics Stock

-₹13,043 (-13.04%)

Dollar Impact

₹7,806 (+7.81%)

Analyst Recommendation on Abeona Therapeutics Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Abeona Therapeutics. Average target price of $18.86

Abeona Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Abeona Therapeutics.

What analysts predicted

68.19%UPSIDE

Target Price

$18.86

Current Price

$6

Analyzed by

2 Analysts

Target

$18.86

Abeona Therapeutics target price $18.86, a slight upside of 68.19% compared to current price of $6. According to 2 analysts rating.

Indian Investors' Interest in Abeona Therapeutics Stock

Search interest for Abeona Therapeutics Stock has decreased by -51% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-51% versus previous 30 day period

Abeona Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
4
-
0
-
5
8
11
Gross Profit
0
0
0
0
0
0
0
2
5
7
Operating Income
-14
-17
-15
-16
-19
-22
-24
-22
-23
-13
EBITDA
-29
9
-28
-7
-10
126
-18
-18
-15
-18
Interest Expense
0
1
1
1
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
1
0
-
Income Before Tax
-31
7
-30
-9
-12
124
-20
-20
-17
-20
Income Tax Expense
0
-1
-
0
-
15
-15
0
0
-
Net Income
-31
7
-30
-9
-12
108
-5
-20
-17
-20
Net Profit Margin
0.00%
0.00%
0.00%
-194.33%
0.00%
27208.25%
0.00%
-377.49%
-195.81%
-177.43%

Abeona Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
2
-
10
3
1
3
-
5
Gross Profit
-9
-16
-35
-48
10
3
0
1
-2
4
Operating Income
-23
-27
-58
-77
-81
-89
-50
-47
-64
-89
EBITDA
-21
-26
-54
-69
-74
-76
-34
-50
-56
78
Interest Expense
0
0
0
0
4
3
0
0
4
3
Depreciation
-
0
2
7
4
3
4
3
2
3
Income Before Tax
-21
-27
-56
-76
-84
-84
-39
-54
-63
71
Income Tax Expense
2
0
1
0
4
3
-7
3
-
0
Net Income
-21
-27
-56
-76
-84
-84
-39
-54
-63
71
Net Profit Margin
-2460.40%
-3263.92%
-1890.29%
0.00%
-842.34%
-2831.20%
-2807.36%
-1548.23%
0.00%
1223.08%

Abeona Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
7
-30
-9
-12
108
-5
-20
-17
-20
Operating Cash Flow
-12
-12
-16
-18
-18
-21
-17
-19
-17
Investing Cash Flow
-44
-6
18
4
155
-64
9
4
15
Financing Cash Flow
73
0
5
6
10
5
3
-2
-3
Change in Cash
16
-18
7
-7
147
-80
-4
-17
-5

Abeona Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-27
-56
-76
-84
-84
-39
-54
-63
71
Operating Cash Flow
-22
-39
-62
-35
-65
-43
-37
-56
-76
Investing Cash Flow
0
-85
59
-83
66
-23
0
-39
105
Financing Cash Flow
92
5
113
1
24
43
37
104
26
Change in Cash
68
-118
111
-116
25
-24
0
8
54

Mutual Funds that own Abeona Therapeutics Stock

Check out the Mutual Funds with significant holdings in Abeona Therapeutics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.654194%
2089615
Fidelity Concord Street Trust
0.910632%
520736
Fidelity Salem Street Trust
0.87636%
501138
VANGUARD SCOTTSDALE FUNDS
0.452288%
258637
SCHWAB CAPITAL TRUST
0.221929%
126908

Global Institutional Holdings in Abeona Therapeutics

Funds
Holdings
Vanguard
4.28%
iShares
3.22%
Eric Andersen
2.19%
Simplify
0.48%
SPDR
0.4%

Insights on Abeona Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ABEO has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, ABEO stock has moved up by 17.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 496.3% return, outperforming this stock by 509.2%

About Abeona Therapeutics

Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
OrganisationAbeona Therapeutics
Headquarters6555 Carnegie Avenue, Cleveland, OH, United States, 44103
IndustryBiotechnology
CEODr. Vishwas Seshadri M.B.A., Ph.D.
E-voting on sharesClick here to vote

Key Management of Abeona Therapeutics

Name

Title

Ms. Gianine Esposito

Senior VP & Chief People Officer

Dr. Madhav Vasanthavada M.B.A., Ph.D.

SVP, Chief Commercial Officer & Head of Business Development

Mr. Carl Denny

Senior Vice President of Regulatory Affairs

Dr. Brendan M. O'Malley J.D., Ph.D.

Chief Legal Officer

Mr. Brian Kevany Ph.D.

Chief Technical & Scientific Officer

Mr. Gregory Gin

Vice President of Investor Relations & Corporate Communications

Mr. Jon Voss

VP & Head of Quality

Ms. Megan Callan

Vice President & Head of Quality

Dr. Vishwas Seshadri M.B.A., Ph.D.

President, CEO & Director

Mr. Joseph Walter Vazzano CPA

Chief Financial Officer

FAQs

What is Abeona Therapeutics share price today?

Abeona Therapeutics share price today is $6.00 as on . Abeona Therapeutics share today touched a day high of $6.04 and a low of $5.93.

What is the 52 week high and 52 week low for Abeona Therapeutics share?

Abeona Therapeutics share touched a 52 week high of $7.65 on and a 52 week low of $4.00 on . Abeona Therapeutics stock price today i.e. is trending at $6.00,which is 21.57% down from its 52 week high and 50.00% up from its 52 week low.

What is Abeona Therapeutics's market capitalisation today?

Abeona Therapeutics market capitalisation is $0.00T as on .

How to invest in Abeona Therapeutics Stock (ABEO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Abeona Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abeona Therapeutics Shares that will get you 0.2500 shares as per Abeona Therapeutics share price of $6.00 per share as on August 27, 2026 at 9:05 pm IST.

What is the minimum amount required to buy Abeona Therapeutics Stock (ABEO) from India?

Indian investors can start investing in Abeona Therapeutics (ABEO) shares with as little as ₹95.53 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.30 in Abeona Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Abeona Therapeutics share’s latest price of $6.00 as on August 27, 2026 at 9:05 pm IST, you will get 1.6667 shares of Abeona Therapeutics. Learn more about fractional shares .

What are the returns that Abeona Therapeutics has given to Indian investors in the last 5 years?

Abeona Therapeutics stock has given -81.04% share price returns and 30.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?